March 25th 2024
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Climacterium and the menopause
October 2nd 2011The world of menopausal care is changing. For many years, the scientific community involved in menopause research has been amassing evidence that the menopause is associated with multiple complaints and chronic diseases, and that postmenopausal hormone therapy has the potential to prevent or treat most of them.
Read More
Aging, Not Menopause, Linked to Increased Risk of Heart Disease
September 30th 2011Hormonal changes associated with menopause do not increase a woman’s risk for heart disease and heart disease mortality, according to new research published in BMJ. The work of Dr Dhananjay Vaidya, assistant professor of medicine at John Hopkins School of Medicine, and colleagues contradict the previously hypothesis that heart disease and heart attacks rise dramatically after menopause.
Read More
Venous Thromboembolism and Estrogen Hormone Therapy: Patch Presents Less Risk Than Pill
September 25th 2011A new study provides a real-world snapshot of risks associated with venous thromboembolism in women receiving hormone replacement therapy, demonstrating that women who use an estradiol transdermal system may have less risk of developing thromboembolism than their counterparts who receive oral estrogen-only hormone therapy agents.
Read More
FDA Bounces Request to Approve Desvenlafaxine (Pristiq) for Menopause
September 21st 2011Pfizer Inc. reports that it has received a "complete response letter" from the Food and Drug Administration (FDA) denying its application to approve desvenlafaxine (Pristiq) for moderate to severe vasomotor symptoms of menopause such as hot flashes.
Read More
Poll: How Are You Managing Women With Sleep Disturbances Who Have Discontinued Hormone Therapy?
September 13th 2011A recent study on sleep disturbances in menopause shows a direct connection to the use of hormone therapy. Specifically, when women stop taking hormone therapy they experienced greater periods of poor sleep, waking up during the night, difficulty falling asleep, waking up to early and not feeling rested.
Read More
Popular Herbal Supplement Shows Promise in Treating Menopausal Sleep Disturbances
September 13th 2011According to results from a new study, a popular herbal remedy may come to the rescue of women suffering from postmenopausal sleep disturbances. About half of postmenopausal women experience some degree of sleep disturbance, which in turn impacts their quality of life.
Read More
Hormone Therapy Discontinuation Linked to Increases in Sleep Disturbances
September 11th 2011Cessation of hormone therapy in menopausal women may result in sleep disturbances, according to a new study in Menopause. Since the hormone therapy has been associated with the alleviation of sleep problems in women experiencing menopausal symptoms, Dr Sarah E Tom, Interdisciplinary Women’s Health Research (IWHR) Scholar at the University of Texas Medical School, and colleagues sought to determine the resulting sleep effects during cessation of hormone therapy.
Read More
Is Menopause a Risk Factor for Developing Diabetes?
August 15th 2011With the rate of diabetes and prediabetes/glucose intolerance increasing, it is imperative for clinicians to help reduce the risk of their patients developing full-blown diabetes as well as to help patients manage the illness.
Read More